Vertex Pharmaceuticals Inc. (VRTX) Social Stream



Vertex Pharmaceuticals Inc. (VRTX): $467.28

6.41 (-1.35%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

B

Add VRTX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#4 of 348

in industry

VERTEX PHARMACEUTICALS INC (VRTX) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering VRTX.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-04 19 $331 $175 $262.5 $421.01 -37.65%
2021-11-19 20 $331 $175 $255 $421.01 -39.43%
2021-11-28 19 $331 $175 $252 $421.01 -40.14%
2021-12-02 19 $341 $175 $252.526 $421.01 -40.02%
2021-12-05 19 $341 $175 $253.315 $421.01 -39.83%
2021-12-09 20 $341 $175 $254.15 $421.01 -39.63%
2022-01-07 20 $341 $175 $255.65 $421.01 -39.28%
2022-01-10 19 $341 $201 $259.894 $421.01 -38.27%
2022-01-26 19 $341 $203 $264.578 $421.01 -37.16%
2022-01-28 19 $341 $208 $268 $421.01 -36.34%
2022-02-03 19 $341 $208 $268.21 $421.01 -36.29%
2022-03-14 18 $341 $208 $268.21 $421.01 -36.29%
2022-03-22 18 $341 $208 $268.421 $421.01 -36.24%
2022-03-31 17 $341 $208 $267.722 $421.01 -36.41%
2022-04-04 17 $350 $208 $270.222 $421.01 -35.82%
2022-04-05 17 $350 $208 $271.888 $421.01 -35.42%
2022-04-13 16 $350 $210 $275.421 $421.01 -34.58%
2022-04-17 16 $350 $210 $278.578 $421.01 -33.83%
2022-05-04 16 $350 $210 $280.631 $421.01 -33.34%
2022-05-06 18 $350 $210 $282.105 $421.01 -32.99%
2022-05-09 19 $350 $210 $283.736 $421.01 -32.61%
2022-05-22 19 $350 $210 $282.479 $421.01 -32.9%
2022-05-23 19 $350 $210 $282.8 $421.01 -32.83%
2022-06-03 19 $350 $210 $284.809 $421.01 -32.35%
2022-06-13 18 $350 $240 $289.222 $421.01 -31.3%
2022-07-26 19 $365 $240 $296.764 $421.01 -29.51%
2022-08-03 19 $365 $240 $298 $421.01 -29.22%
2022-08-05 20 $365 $240 $298 $421.01 -29.22%
2022-08-08 20 $365 $250 $301.526 $421.01 -28.38%
2022-08-14 20 $365 $250 $301.684 $421.01 -28.34%
2022-09-27 20 $365 $250 $303.368 $421.01 -27.94%
2022-10-12 20 $365 $250 $303.631 $421.01 -27.88%
2022-10-16 20 $365 $250 $303.894 $421.01 -27.82%
2022-10-21 20 $365 $250 $304.157 $421.01 -27.76%
2022-10-28 20 $365 $250 $304.578 $421.01 -27.66%
2022-10-31 20 $365 $250 $307 $421.01 -27.08%
2022-11-11 20 $365 $250 $311.578 $421.01 -25.99%
2022-12-08 20 $365 $250 $312.631 $421.01 -25.74%
2023-01-09 20 $365 $250 $312.631 $421.01 -25.74%
2023-01-17 20 $374 $250 $318.368 $421.01 -24.38%
2023-01-18 20 $374 $250 $321 $421.01 -23.75%
2023-01-23 19 $374 $250 $321 $421.01 -23.75%
2023-01-27 19 $374 $250 $321.055 $421.01 -23.74%
2023-02-07 18 $374 $250 $321.055 $421.01 -23.74%
2023-02-08 18 $374 $250 $319.944 $421.01 -24.01%
2023-02-09 18 $365 $250 $322.222 $421.01 -23.46%
2023-02-13 17 $365 $250 $326.117 $421.01 -22.54%
2023-03-29 18 $365 $250 $327.111 $421.01 -22.3%
2023-05-01 18 $365 $250 $327.235 $421.01 -22.27%
2023-05-03 20 $456 $288 $360.941 $421.01 -14.27%
2023-05-04 22 $456 $305 $365.631 $421.01 -13.15%
2023-06-06 22 $456 $305 $366.45 $421.01 -12.96%
2023-06-14 22 $456 $305 $366.85 $421.01 -12.86%
2023-06-22 21 $456 $305 $368.105 $421.01 -12.57%
2023-06-26 22 $456 $305 $368.65 $421.01 -12.44%
2023-06-29 22 $456 $305 $369.15 $421.01 -12.32%
2023-06-30 22 $456 $323 $370.9 $421.01 -11.9%
2023-07-20 22 $456 $323 $373.2 $421.01 -11.36%
2023-07-24 22 $456 $323 $375.7 $421.01 -10.76%
2023-08-02 23 $456 $323 $375.7 $421.01 -10.76%
2023-08-03 24 $456 $325 $385.095 $421.01 -8.53%
2023-08-07 24 $456 $315 $381.909 $421.01 -9.29%
2023-09-29 24 $456 $315 $382.136 $421.01 -9.23%
2023-10-09 24 $456 $315 $382.454 $421.01 -9.16%
2023-10-25 25 $456 $315 $383.59 $421.01 -8.89%
2023-11-06 25 $456 $315 $382.782 $421.01 -9.08%
2023-11-08 25 $456 $315 $391.347 $421.01 -7.05%
2023-11-10 25 $456 $315 $392.652 $421.01 -6.74%
2023-12-13 26 $456 $315 $392 $421.01 -6.89%
2023-12-14 26 $485 $315 $393.791 $421.01 -6.47%
2023-12-22 26 $485 $315 $395.75 $421.01 -6%

The Trend in the Analyst Price Target


VRTX's average price target has moved up $135.02 over the prior 30 months.

VRTX reports an average of 4.39% for its upside potential over the past 48 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-02-08 18 374 250 319.944 293.33 9.07%
2023-03-29 18 365 250 327.111 314.24 4.1%
2023-04-16 18 365 250 327.235 333.52 -1.88%
2023-11-06 25 456 315 382.782 385.76 -0.77%
2023-12-14 26 485 315 395.125 406.60 -2.82%

VRTX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.62 18 0 8 0 0 26

The Trend in the Broker Recommendations


Over the past 46 months, VRTX's average broker recommendation rating worsened by 0.16.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, VERTEX PHARMACEUTICALS INC's average analyst price target is higher than 8562.51% of them.
  • VERTEX PHARMACEUTICALS INC's number of analysts covering the stock is greater than 8597.49% of Pharmaceutical Products stocks.
  • To contextualize these metrics, consider that out of Healthcare stocks, VERTEX PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 543.19% of them.
  • VRTX has a lower variance in analysts' estimates than -2335.73% of Pharmaceutical Products stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to VERTEX PHARMACEUTICALS INC are RPRX, RGNX, and HALO.

Make investment decisions regarding VRTX using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!